Hemophilia Federation - Nashik Chapter Profile
Key Indicators
- Authorised Capital ₹ 15.00 K
as on 16-12-2024
- Paid Up Capital ₹ 15.00 K
as on 16-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 584.70%
(FY 2020)
- Profit -871.57%
(FY 2020)
- Ebitda -24.66%
(FY 2020)
- Net Worth 0.16%
(FY 2020)
- Total Assets 0.16%
(FY 2020)
About Hemophilia Federation - Nashik Chapter
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 K and a paid-up capital of Rs 15.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ranjana Kulkarni, Kishor Gaidhani, and Sudhir Kulkarni serve as directors at the Company.
- CIN/LLPIN
U74999MH2017NPL294548
- Company No.
294548
- Company Classification
Private Not For Profit Company
- Incorporation Date
01 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hemophilia Federation - Nashik Chapter?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjana Kulkarni  | Director | 01-May-2017 | Current |
| Kishor Gaidhani | Director | 01-May-2017 | Current |
| Sudhir Kulkarni | Director | 01-May-2017 | Current |
Financial Performance of Hemophilia Federation - Nashik Chapter.
Hemophilia Federation - Nashik Chapter, for the financial year ended 2020, experienced significant growth in revenue, with a 584.7% increase. The company also saw a substantial fall in profitability, with a 871.57% decrease in profit. The company's net worth moved up by a moderate rise of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemophilia Federation - Nashik Chapter?
Unlock access to Hemophilia Federation - Nashik Chapter's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lifeline Hospital And Medical Research Centre (India) Privete LimitedActive 39 years 11 monthsSudhir Kulkarni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hemophilia Federation - Nashik Chapter?
Unlock and access historical data on people associated with Hemophilia Federation - Nashik Chapter, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemophilia Federation - Nashik Chapter, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemophilia Federation - Nashik Chapter's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
